Status:

COMPLETED

Optimisation and Performance of Reduced Preparation CT Colography

Lead Sponsor:

London North West Healthcare NHS Trust

Collaborating Sponsors:

St Mark's Foundation

Conditions:

Patients With Potential Colorectal Neoplasia

Eligibility:

All Genders

50+ years

Phase:

PHASE4

Brief Summary

To ascertain which of four combinations of low residue diet, reduced laxative dose and oral contrast agent is best tolerated by patients and optimally prepares the colon prior ro CT colonography

Detailed Description

CT colonography has been shown to be accurate in detection of colorectal neoplasia in enriched patient populations and is generally preferred by patients to conventional endoscopy and barium enema. It...

Eligibility Criteria

Inclusion

  • Patients who are under investigation for suspected colonic neoplasia and over 50 years old:
  • Symptomatic patients eg. change in bowel habit, rectal bleeding etc.
  • Polyp surveillance
  • Strong family history
  • suspected neoplasia on previous investigation (e.g. barium enema)

Exclusion

  • patients under 50 patients undergoing surveillance for inflammatory bowel disease (due to poor diagnostic use of CT colonography in this specific patient cohort)

Key Trial Info

Start Date :

July 1 2004

Trial Type :

INTERVENTIONAL

End Date :

February 1 2006

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT00212433

Start Date

July 1 2004

End Date

February 1 2006

Last Update

May 23 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

St Mark's Hospital, North West London Hospitals NHS Trust

London, Middlesex, United Kingdom, HA1 3UJ

2

University College Hospital

London, United Kingdom, NW1 2BU

3

Oxford Radcliffe Hospital NHS Trust

Oxford, United Kingdom